HELICOBACTER PYLORI FIRST-LINE AND RESCUE TREATMENTS IN THE PRESENCE OF PENICILLIN ALLERGY

被引：0
|
作者：
Gisbert, J. P. [1 ,2 ]
Barrio, J. [3 ]
Modolell, I. [4 ]
Molina-Infante, J. [5 ]
Perez-Aisa, A. [6 ]
Castro-Fernandez, M. [7 ]
Rodrigo, L. [8 ]
Cosme, A. [9 ]
Gisbert, J. L. [1 ,2 ]
Fernandez-Bermejo, M. [5 ]
Marcos, S. [1 ,2 ]
Marin, A. C. [1 ,2 ]
McNicholl, A. G. [1 ,2 ]
机构：
[1] Hosp Princesa, IP, Madrid, Spain
[2] CIBEREHD, Madrid, Spain
[3] Hosp Rio Hortega, Valladolid, Spain
[4] Consorci Sanitari Terrassa, Barcelona, Spain
[5] Hosp San Pedro de Alcantara, Caceres, Spain
[6] Agencia Sanitaria Costa del Sol, Marbella, Spain
[7] Hosp Valme, Seville, Spain
[8] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain
[9] Hosp Donostia, San Sebastian, Spain
来源：
HELICOBACTER | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P11.07
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [21] Levofloxacin in first-line treatment of Helicobacter pylori infection
    Rispo, A.
    Di Girolamo, E.
    Cozzolino, A.
    Bozzi, R.
    Morante, A.
    Pasquale, L.
    HELICOBACTER, 2007, 12 (04) : 364 - 365
  • [22] Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
    Song, Zhiqiang
    Fu, Wei
    Zhou, Liya
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [23] Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
    Zhiqiang Song
    Wei Fu
    Liya Zhou
    BMC Gastroenterology, 19
  • [24] Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin"
    Ribaldone, Davide Giuseppe
    Astegiano, Marco
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [25] Response to: Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin"
    Sue, Soichiro
    Suzuki, Nobumi
    Shibata, Wataru
    Sasaki, Tomohiko
    Yamada, Hiroaki
    Kaneko, Hiroaki
    Tamura, Toshihide
    Ishii, Tomohiro
    Kondo, Masaaki
    Maeda, Shin
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [26] HELICOBACTER PYLORI FIRST-LINE TREATMENT WITH BISMUTH-CONTAINING QUADRUPLE THERAPY, AND SECOND-LINE LEVOFLOXACIN-BASED RESCUE OPTION, IN PATIENTS ALLERGIC TO PENICILLIN
    Gisbert, J. P.
    Barrio, J.
    Modolell, I.
    Molina-Infante, J.
    Perez-Aisa, A.
    Gisbert, J. L.
    Fernandez-Bermejo, M.
    Marcos, S.
    HELICOBACTER, 2013, 18 : 132 - 132
  • [27] Helicobacter pylori First-Line Treatment With Bismuth-Containing Quadruple Therapy, and Second-Line Levofloxacin-Based Rescue Option, in Patients Allergic to Penicillin
    Gisbert, Javier P.
    Barrio, Jesus
    Modolell, Ines
    Molina-Infante, Javier
    Aisa, Angeles Perez
    Gisbert, JoseLuis
    Bermejo, Miguel Fernandez
    Marcos, Santiago
    GASTROENTEROLOGY, 2014, 146 (05) : S393 - S393
  • [28] Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies
    Luo Laisheng
    Huang Yu
    Liang Xiao
    Ji Yingjie
    Yu Lou
    Lu Hong
    HELICOBACTER, 2020, 25 (04)
  • [29] H. pylori First-Line Treatment and Levofloxacin-Based Rescue Option in Patients Allergic to Penicillin
    Gisbert, J. P.
    Perez-Aisa, A.
    Castro-Fernandez, M.
    Barrio, J.
    Rodrigo, L.
    Cosme, A.
    Gisbert, J. L.
    Marcos, S.
    Moreno-Otero, R.
    HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [30] Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment
    Cisaro, F.
    Astegiano, M.
    De Angelis, C.
    Saracco, G.
    Rizzetto, M.
    Pellicano, R.
    PANMINERVA MEDICA, 2011, 53 (02) : 138 - 138
12345